A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
Clinical trial NCT06336291 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06336291
- Sponsor
- Philogen S.p.A.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-22
- Primary completion
- 2026-06-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.